Chong Kun Dang Pharmaceutical종근당
185750 · KOSPI · ₩185750 · 종근당
₩61,900▲ ₩600 (0.98%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 29.8% | 31.1% | 33.6% | 39.7% | 36.5% | 36.9% |
| Operating margin | 4.3% | 4.8% | 6.3% | 14.8% | 7.4% | 7.1% |
| Net margin | 4.5% | 4.6% | 6.9% | 12.7% | 5.4% | 3.2% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +5.3% | +6.7% | −5.0% | +12.2% | +10.8% | — |
| Operating income growth | −4.2% | −19.0% | −59.7% | +124.4% | +16.0% | — |
| Net income growth | +2.5% | −28.9% | −48.7% | +162.5% | +89.5% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 7.9% | 8.2% | 12.8% | 29.6% | 13.6% | 7.5% |
| Return on assets | 4.3% | 4.8% | 7.8% | 16.9% | 7.4% | 4.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 83.3% | 78.9% | 62.7% | 71.9% | 81.1% | 85.0% |
| Net debt to equity | 13.9% | 3.3% | −13.2% | −18.5% | 18.8% | 18.0% |
| Current ratio | 204.3% | 211.5% | 261.1% | 185.1% | 190.7% | 208.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Chong Kun Dang Pharmaceutical / 종근당 / 185750 / KRX:185750
Source: KRX statistical information